PTC Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Cytokinetics USD 938.22M 843.36M 2025-03
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 39.67M 1.2M 2025-03



PTC Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.